 |
| Patrick Schmick, right, CEO of PhytoLife Pharma, poses with Dr. Jalid Sehouli, director of Gynecology at Charite Hospital Berlin, at Expopharm 2022. / Courtesy of Naturalendo Tech |
Sales of Naturalendo Tech's "Menoelle," a health functional food for menopausal women sourced from EstroG-100, have spiked in Europe since its launch there in 2019. The success has been verified from a recent interview with Patrick Schmick, CEO of PhytoLife Pharma, a Berlin-based company marketing Naturalendo Tech's products of the Menoelle brand in Europe.
"The key to success is the mix of emotional marketing concepts, strong end consumer campaigns and the close cooperation with doctors and pharmacists," said Schmick, who is also co-founder and part of the management of the Korean-based NaturaLife Asia Group.
He says Naturalendo Tech's products are successfully sold throughout Germany under the Menoelle brand via pharmacies, drugstores and pharmaceutical online retailers. "Since last year, Menoelle has also been offered in the Netherlands, Austria and Switzerland. Market launches in France and the U.K. will follow in early 2023," Schmick said, adding that EstroG-100 and other Menoelle brand products will be available in all European countries by the end of 2025.
Asked why menopause is such a prominent topic in Europe, he said that's because there are nearly 100 million menopausal consumers in the European Union, including 18 million in Germany alone. "By 2025, over 1 billion women worldwide will enter menopause equaling 12 percent of the total world population. We expect menopause to be one of the outstanding and relevant topics of the next decade," said Schmick who founded PhytoLife Pharma in 2017.
He painted a rosy picture for EstroG-100, saying it is gaining a positive reputation by medical professionals at a time when there is a strong market trend for natural, effective and safe remedies with strong clinical research. "EstroG-100 is the only herbal active ingredient recognized worldwide and proven by extensive multiple clinical studies, which on a hormone-free basis and without side effects cures 12 menopausal symptoms, gives sustainable relief and can be taken long-term," Schmick explained.
When asked about PhytoLife Pharma's unique points, he said the company researches, develops and manufactures innovative medical products as well as digital applications in the field of women's health, especially in the area of "menopause."
![[RAS KOREA] Preserving memories at Cheongju City Archives](https://img.koreatimes.co.kr/upload/thumbnailV2/53ecc69c116c49af9ba0005288526ab5.jpg/dims/resize/178/optimize)
![[INTERVIEW] Long-awaited extension of Korean Pavilion at Venice Biennale to be pushed forward](https://img.koreatimes.co.kr/upload/thumbnailV2/d8d5090875824ce08a90bb2c5a8f8c05.jpg/dims/resize/178/optimize)
